Literature DB >> 28488549

Prevalence of F5 1691G>A, F2 20210G>A, and MTHFR 677C>T polymorphisms in Bosnian women with pregnancy loss.

Emir Mahmutbegović1, Damir Marjanović, Edin Medjedović, Nevena Mahmutbegović, Serkan Dogan, Amina Valjevac, Ewa Czerska, Anna Pawińska-Matecka, Agnieszka Madlani, Grażyna Adler.   

Abstract

The relationship between genetic risk factors of thrombophilia and pregnancy loss (PL) is being discussed. The focus has been on F5 1691G>A, F2 20210G>A, and MTHFR 677C>T polymorphisms that may predispose women to microthrombosis during the stages of embryo implantation and placentation. Although, the frequencies of these polymorphisms were reported in different populations, such studies have not yet been performed in Bosnian population. In this study, we determined the prevalence of F5 G>A (rs6025), F2 G>A (rs1799963) and MTHFR C>T (rs1801133) polymorphisms in Bosnian women. A total of 154 women with PL, mean age 33 (±5.4) years, were enrolled in the study. As a control group, 154 mothers [mean age 31.4 (±6.7) years] with at least one live-born child were included. We used real-time polymerase chain reaction (PCR) to determine the frequencies of F5 G>A and F2 G>A genotypes, and PCR-restriction fragment length polymorphism (RFLP) for analyzing MTHFR C>T genotypes. The frequency of heterozygotes for F5 and F2 was significantly higher in women with venous thrombosis (VT) compared to women without VT (p = 0.047 and p = 0.001, respectively). There was no significant difference in the distribution of MTHFR genotypes and alleles between these two groups. In addition, we observed no significant differences in the genotype and allele frequencies between the group with PL and control group, for all investigated polymorphisms. The allele frequencies for 1691A (F5), 20210A (F2), and 677T (MTHFR) reported in this study are consistent with the data obtained for other European countries, however, we were not able to confirm the association between the three polymorphisms and PL in Bosnian women.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28488549      PMCID: PMC5708901          DOI: 10.17305/bjbms.2017.1954

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  27 in total

1.  Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages.

Authors:  Z J Foka; A F Lambropoulos; H Saravelos; G B Karas; A Karavida; T Agorastos; V Zournatzi; P E Makris; J Bontis; A Kotsis
Journal:  Hum Reprod       Date:  2000-02       Impact factor: 6.918

2.  Factor V Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis.

Authors:  Christine Biron-Andreani; Jean-Francois Schved; Jean-Pierre Daures
Journal:  Thromb Haemost       Date:  2006-07       Impact factor: 5.249

3.  Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study.

Authors:  C Schmitz; K Lindpaintner; P Verhoef; J M Gaziano; J Buring
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

Review 4.  Hemostasis during normal pregnancy and puerperium.

Authors:  Margareta Hellgren
Journal:  Semin Thromb Hemost       Date:  2003-04       Impact factor: 4.180

Review 5.  Thrombophilia in pregnancy.

Authors:  I D Walker
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

6.  Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss.

Authors:  Howard Carp; Ophira Salomon; Daniel Seidman; Rima Dardik; Nurith Rosenberg; Aida Inbal
Journal:  Hum Reprod       Date:  2002-06       Impact factor: 6.918

7.  Association between factor V Leiden mutation and poor pregnancy outcomes among Palestinian women.

Authors:  Ayman S Hussein; Hisham Darwish; Khaled Shelbayeh
Journal:  Thromb Res       Date:  2010-06-01       Impact factor: 3.944

8.  Thrombophilic disorders and fetal loss: a meta-analysis.

Authors:  Evelyne Rey; Susan R Kahn; Michèle David; Ian Shrier
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

Review 9.  Thrombophilia in pregnancy: a systematic review.

Authors:  L Robertson; O Wu; P Langhorne; S Twaddle; P Clark; G D O Lowe; I D Walker; M Greaves; I Brenkel; L Regan; I A Greer
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

10.  Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.

Authors:  Ramzi R Finan; Hala Tamim; Ghada Ameen; Huda E Sharida; Mooza Rashid; Wassim Y Almawi
Journal:  Am J Hematol       Date:  2002-12       Impact factor: 10.047

View more
  4 in total

1.  Evaluating the Association Between Genetic Polymorphisms Related to Homocysteine Metabolism and Unexplained Recurrent Pregnancy Loss in Women.

Authors:  Nhat Nguyen Ngoc; My Tran Ngoc Thao; Sang Trieu Tien; Son Vu Tung; Hoang Le; Hung Ho Sy; Tung Nguyen Thanh; Son Trinh The
Journal:  Appl Clin Genet       Date:  2022-06-07

Review 2.  Factor V Leiden 1691G > A mutation and the risk of recurrent pregnancy loss (RPL): systematic review and meta-analysis.

Authors:  Mohammad Masoud Eslami; Majid Khalili; Mina Soufizomorrod; Saeid Abroun; Bahman Razi
Journal:  Thromb J       Date:  2020-06-24

3.  The Frequency of the 677C>T and 1298A>C Polymorphisms in the Methylenetetrahydrofolate Reductase (MTHFR) Gene in the Population.

Authors:  Hilada Nefic; Mirela Mackic-Djurovic; Izet Eminovic
Journal:  Med Arch       Date:  2018-06

4.  Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina.

Authors:  Adna Ašić; Ramona Salazar; Niels Storm; Serkan Doğan; Wolfgang Höppner; Damir Marjanović; Dragan Primorac
Journal:  Croat Med J       Date:  2019-06-13       Impact factor: 1.351

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.